NCT01305525

A Prospective Clinical Outcomes Registry

Partnership for Advancement In Neuromodulation (PAIN): A Prospective Clinical Outcomes Registry

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 614 (actual)
• Sponsor: Abbott Medical Devices · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a prospective non-interventional 24 month post implant registry. Any patient that receives a St. Jude Medical FDA approved implantable neuromodulation system is eligible for enrollment. A minimum of 600 patients will be enrolled from a minimum of 30 sites. Patients will be enrolled post-implant and followed for 24 months. Data are collected at enrollment (within 30 days of device implant), and routine care follow-up visits at 3 months, 6 months, 12 months, 18 months and 24 months.

Conditions

• Pain

Interventions

Type	Name	Description
DEVICE	St. Jude Medical Spinal Cord Stimulation Systems	Spinal cord stimulation

Timeline

• Start date: 2009-06-01
• Primary completion: 2014-04-01
• Completion: 2014-04-01
• First posted: 2011-02-28
• Last updated: 2019-01-30

Locations

32 sites across 2 countries: United States, Puerto Rico